6.24
전일 마감가:
$4.05
열려 있는:
$6.3
하루 거래량:
83.49M
Relative Volume:
60.19
시가총액:
$11.73M
수익:
$15.66M
순이익/손실:
$5.83M
주가수익비율:
-0.2612
EPS:
-23.8939
순현금흐름:
$466.20K
1주 성능:
-59.79%
1개월 성능:
-45.50%
6개월 성능:
+20.23%
1년 성능:
+0.00%
Neuphoria Therapeutics Inc Stock (NEUP) Company Profile
명칭
Neuphoria Therapeutics Inc
전화
781-439-5551
주소
100 SUMMIT DR, BURLINGTON
NEUP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
NEUP
Neuphoria Therapeutics Inc
|
6.24 | 9.55M | 15.66M | 5.83M | 466.20K | -23.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.39 | 108.36B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
463.43 | 60.82B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
577.95 | 61.02B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
817.32 | 50.01B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
310.81 | 34.05B | 4.56B | -176.77M | 225.30M | -1.7177 |
Neuphoria Therapeutics Inc Stock (NEUP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-09-28 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2023-09-28 | 재확인 | Maxim Group | Buy |
| 2022-01-10 | 개시 | Berenberg | Buy |
| 2022-01-10 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-01-10 | 개시 | Evercore ISI | Outperform |
| 2022-01-10 | 개시 | H.C. Wainwright | Buy |
모두보기
Neuphoria Therapeutics Inc 주식(NEUP)의 최신 뉴스
Can Neuphoria Therapeutics Inc. stock hit analyst price targets2025 Growth vs Value & Risk Managed Investment Entry Signals - newser.com
Using AI based signals to follow Neuphoria Therapeutics Inc.July 2025 Closing Moves & High Yield Stock Recommendations - newser.com
Automated trading signals detected on Neuphoria Therapeutics Inc.Exit Point & Momentum Based Trading Ideas - newser.com
How Neuphoria Therapeutics Inc. stock performs in interest rate cyclesTrade Entry Summary & Weekly High Momentum Picks - newser.com
Can Neuphoria Therapeutics Inc. stock rebound after recent weaknessTrade Exit Summary & Expert Curated Trade Ideas - newser.com
Why analysts upgrade Neuphoria Therapeutics Inc. stockGold Moves & Daily Entry Point Alerts - newser.com
Is Neuphoria Therapeutics Inc. stock attractive after correctionBear Alert & Real-Time Stock Movement Alerts - newser.com
Neuphoria Therapeutics Inc.’s volatility index tracking explainedPortfolio Profit Report & High Win Rate Trade Alerts - newser.com
Why hedge funds are buying Neuphoria Therapeutics Inc. stockInsider Selling & Stepwise Trade Execution Plans - newser.com
Will Neuphoria Therapeutics Inc. stock keep outperforming rivalsTrade Exit Summary & Weekly High Potential Alerts - newser.com
Best Biotech Stocks To Keep An Eye OnOctober 25th - MarketBeat
Published on: 2025-10-26 10:45:26 - newser.com
Neuphoria Therapeutics Advances BNC-210 Trial with Prolonged Cash Runway - StocksToTrade
Published on: 2025-10-26 11:32:54 - newser.com
Can Neuphoria Therapeutics Inc. stock maintain operating marginsJuly 2025 PostEarnings & Precise Buy Zone Identification - newser.com
Published on: 2025-10-25 19:04:06 - newser.com
Neuphoria Therapeutics Stock Gains Amid Phase 3 Trial Advances - StocksToTrade
Neuphoria Therapeutics Advances Social Anxiety Drug in Key Phase 3 Trial - timothysykes.com
Neuphoria Therapeutics Inc (NEUP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):